Skip to nav Skip to content
View All Guidelines
IDSA PRACTICE GUIDELINES ARCHIVED IN DEVELOPMENT

PIDS/IDSA Guidelines for the Management of Community-Acquired Pneumonia (CAP) in Infants and Children Older Than 3 Months of Age

Download PDF

PublishedOctober 01, 2011

Clinical Infectious Diseases, Volume 53, Issue 7, 1 October 2011, Pages e25–e76, https://doi.org/10.1093/cid/cir531
 
Published: 01 October 2011
 
This guideline is currently in development. 

John S. Bradley, Carrie L. Byington, Samir S. Shah, Brian Alverson, Edward R. Carter, Christopher Harrison, Sheldon L. Kaplan, Sharon E. Mace, George H. McCracken, Matthew R. Moore, Shawn D. St Peter, Jana A. Stockwell, Jack T. Swanson

Update Status

This guideline is currently in development. 

Abstract

Evidenced-based guidelines for management of infants and children with community-acquired pneumonia (CAP) were prepared by an expert panel comprising clinicians and investigators representing community pediatrics, public health, and the pediatric specialties of critical care, emergency medicine, hospital medicine, infectious diseases, pulmonology, and surgery. These guidelines are intended for use by primary care and subspecialty providers responsible for the management of otherwise healthy infants and children with CAP in both outpatient and inpatient settings. Site-of-care management, diagnosis, antimicrobial and adjunctive surgical therapy, and prevention are discussed. Areas that warrant future investigations are also highlighted.

For the full list of references, please visit Oxford Academic, Clinical Infectious Diseases online.

Publication Disclaimer

© IDSA <2011>. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, transmitted, used for text and data mining, or used for training artificial intelligence, in any form or by any means, without the prior permission in writing, or as expressly permitted by law, by license or under terms agreed with the appropriate reprographics rights organization. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through the Oxford University Press RightsLink service via the Permissions link for this paper in Clinical Infectious Diseases. For further information please contact journals.permissions@oup.com.
Back to top

Table of Contents